Home Podcasts ACC CardiaCast
ACC CardiaCast

ACC CardiaCast

American College of Cardiology 100 Episodes Oct 9, 2026

ACC CardiaCast is an occasional series from the American College of Cardiology. It offers the latest in clinical education, featuring explorations of current research and interviews with cardiovascular experts. The podcast aims to keep clinicians informed about advancements in cardiology.

Episodes

What Clinicians May Be Missing: Overcoming Barriers to Aortic Stenosis Diagnosis
What Clinicians May Be Missing: Overcoming Barriers to Aortic Stenosis Diagnosis Oct 9, 2026 19:16 This episode is part of ACC's ongoing initiative to review aortic stenosis care and its approach to screening and diagnosis. Drs. Wayne Batchelor and Sammy Elmariah review the barriers to aortic stenosis diagnosis. The conversation highlights symptom variability, sex-based and demographic differences, and screening gaps in the real-world practice.    This podcast is part of the ACC's Transformi
Intersections in Dyslipidemia and Cardiometabolic Syndrome Management
Intersections in Dyslipidemia and Cardiometabolic Syndrome Management Sep 28, 2026 16:51 This episode is part of ACC's ongoing initiative on implementing the 2026 Dyslipidemia guidelines. Join Drs. Samuel Kim and Romit Bhattacharya as they review new therapeutic developments from the guidelines during this discussion on the intersections of dyslipidemia and cardiometabolic syndrome management.   This podcast is part of the ACC's Implementing the 2026 Dyslipidemia Guidelines: From
Mastering the Diagnostic Work-up: From Fasting Lipids to FCS Evaluation
Mastering the Diagnostic Work-up: From Fasting Lipids to FCS Evaluation Sep 25, 2026 15:52 This episode is part of ACC's ongoing initiative to recognize the risks and tackle management of hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG). Drs. Michael Miller and Archna Bajaj discuss the importance of correctly diagnosing sHTG, recognizing familial chylomicronemia syndrome (FCS), and following guideline‑based testing sequences.  This podcast is part of the ACC's Hypert
Future Directions in ATTR-CM Treatment
Future Directions in ATTR-CM Treatment Sep 18, 2026 24:40 In this CardiaCast episode, Kevin M. Alexander, MD is joined by Sarah Cuddy, MBBCh, to discuss the latest clinical data for investigational therapies and available treatments for transthyretin amyloid cardiomyopathy (ATTR-CM), as well as the potential implications of these findings on clinical practice and future clinical studies. First, they will explore results from CARDIO-TTRansform, the phase
Risk Assessment and Genetics in the Prevention of Cardiovascular Disease
Risk Assessment and Genetics in the Prevention of Cardiovascular Disease Aug 10, 2026 22:17 This episode of CardiaCast will feature a discussion on risk assessment and genetics in the prevention of cardiovascular disease.   This podcast is supported by Esperion, Merck, and Novartis.
Risk Assessment and Treatment of Hypertriglyceridemia
Risk Assessment and Treatment of Hypertriglyceridemia Aug 7, 2026 22:16 This episode of CardiaCast will feature a discussion on risk assessment and the treatment of hypertriglyceridemia.   This podcast is supported by Esperion, Merck, and Novartis. 
Targeting UACR: Therapeutic and Behavioral Approaches
Targeting UACR: Therapeutic and Behavioral Approaches Jul 31, 2026 18:29 In this final episode of the Increasing Role of UACR in Cardiovascular Care series, Drs. Ankeet Bhatt and Brendan Neuen will break down why UACR screening is one of the most powerful yet underused tools for identifying early cardiovascular risk. Together, they examine the latest evidence on therapies and lifestyle strategies that reduce albuminuria, discuss their impact on kidney and cardiovascula
Beyond the Kidneys: UACR and Cardiovascular Risk
Beyond the Kidneys: UACR and Cardiovascular Risk Jul 24, 2026 14:44 The second episode of the Increasing Role of UACR in Cardiovascular Care series focuses on the most recent evidence-based guidelines for elevated UACR and related cardiovascular (CV) conditions. Dr. Ankeet Bhatt interviews Dr. Nihar Desai on key terminology for albuminuria and discuss CV conditions associated with UACR as a biomarker.   This podcast is supported by a grant from Boehringer Ingel
Treatment of ASCVD Risk: From Lifestyle to Advanced Therapies
Treatment of ASCVD Risk: From Lifestyle to Advanced Therapies Jul 20, 2026 24:27 This episode of CardiaCast will feature a discussion on the treatment of atherosclerotic cardiovascular disease (ASCVD) risk – from lifestyle to advanced therapies, led by Dr. Maya Safarova. The conversation covers lifestyle "therapy", the treatment algorithm for primary and secondary prevention, and what's on the horizon for ASCVD.   This podcast is supported by Esperion, Merck, and Novartis. 
The What, Who, When and Why of Screening of UACR
The What, Who, When and Why of Screening of UACR Jul 17, 2026 21:35 In this first episode of The Increasing Role of Urine Albumin-Creatinine Ratio (UACR) in Cardiovascular Care series, Dr. Ankeet Bhatt interviews Dr. Katherine Tuttle on UACR, its role in kidney disease, and the importance of screening. Listen to Dr. Tuttle provide an overview of the most recent evidence-based practices for UACR screening in cardiovascular disease risk assessment.  This podcast
Understanding the Spectrum: Causes and Risks of HTG and sHTG
Understanding the Spectrum: Causes and Risks of HTG and sHTG Jun 29, 2026 13:35 This episode is part of ACC's ongoing initiative to recognize the risks and tackle management of Hypertriglyceridemia (HTG) and Severe Hypertriglyceridemia (sHTG). Drs. Michael Miller and Monica Aggarwal review and emphasize the need to understand the multifactorial and genetic causes of HTG and sHTG, as well as the associated risks of pancreatitis and ASCVD.  This podcast is part of the ACC's 
Treating PSVT
Treating PSVT Jun 19, 2026 23:53 This episode is part of ACC's ongoing educational initiative to enhance the recognition, diagnosis, and management of paroxysmal supraventricular tachycardia (PSVT). Faculty review contemporary acute treatment approaches, including established therapies, recent advances, and first-line emergency department strategies with attention to efficacy and safety. The discussion also addresses management

Recommended